| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 11/11/2009 | EP2114411A2 Composition and method for protecting mitochondria |
| 11/11/2009 | EP2114407A1 Use of sodium blockers for an early therapy of obstructive lung diseases |
| 11/11/2009 | EP2114399A2 R-zileuton for use in conditions associated with increased 5-lipoxygenase and/or leukotriene activity (eg asthma) |
| 11/11/2009 | EP1818052B1 Use of formoterol in the prophylactic and/or therapeutic treatment of muscle wasting and/or cachectic syndrome which are associated with catabolic conditions of certain diseases, such as cancer, aids, infections, diabetes and others |
| 11/11/2009 | EP1778673B1 Novel hydantoin derivatives for the treatment of obstructive airway diseases |
| 11/11/2009 | EP1575964B1 N-(benzyl)aminoalkyl carboxylate, phosphinates, phosphonates and tetrazoles as edg receptor agonists |
| 11/11/2009 | EP1372634B1 Use of fumaric acid amides |
| 11/11/2009 | EP1315812B1 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 11/11/2009 | EP1255726B1 (r)-2-aryl-propionamides, useful in the inhibition of il-8 induced chemiotaxis of neutrophils |
| 11/11/2009 | EP1191943B1 Anti-allergic peptides |
| 11/11/2009 | CN101578265A Sulfonamide derivatives as chymase inhibitors |
| 11/11/2009 | CN101578120A Compounds and compositions as channel activating protease inhibitors |
| 11/11/2009 | CN101578097A Anesthetic spray composition |
| 11/11/2009 | CN101575365A Antiviral protein and preparation method and application thereof |
| 11/11/2009 | CN101575361A Novel specific polypeptide and application thereof in preparing medicament for diagnosing, preventing and treating severe acute respiratory syndrome caused by coronaviruses |
| 11/11/2009 | CN101574552A Inhalation kit comprising inhalable powder of tiotropium |
| 11/11/2009 | CN101574520A Methods of administering anti-TNF alpha antibodies |
| 11/11/2009 | CN101574508A Traditional Chinese medicine for treating flu in swinery |
| 11/11/2009 | CN101574495A Method for controlling quality of honeysuckle flower mango capsule |
| 11/11/2009 | CN101574486A Quality control method for Chinese medicinal capsule for treating anemofrigid cold |
| 11/11/2009 | CN101574475A Polygonatum particle and preparation method thereof |
| 11/11/2009 | CN101574470A Composition with function of clearing throat and preparation method thereof |
| 11/11/2009 | CN101574469A Traditional Chinese medicine for treating passionate type swine plague |
| 11/11/2009 | CN101574468A Chinese medicament for treating globus hystericus |
| 11/11/2009 | CN101574441A Composition with function of clearing throat and preparation method thereof |
| 11/11/2009 | CN101574425A Child cough granule and preparation method of same |
| 11/11/2009 | CN101574419A Composition with throat-clearing function, and preparation method thereof |
| 11/11/2009 | CN101574415A Patch for preventing and treating external infection |
| 11/11/2009 | CN101574399A Composition with function of moistening and cleaning throat and preparation method thereof |
| 11/11/2009 | CN101574395A Method for producing schisandra extract by adopting high voltage pulse electric field technology |
| 11/11/2009 | CN101574392A Prevention and treatment of diseases induced by microcirculation disturbance with total salvianolic acid |
| 11/11/2009 | CN101574391A Prevention and treatment of diseases induced by microcirculation disturbance with compatible combination of total salvianolic acid and panax notoginoside |
| 11/11/2009 | CN101574389A Dripping pill for treating pharyngeal and laryngeal diseases and preparation method thereof |
| 11/11/2009 | CN101574387A Quality control method for stringy stonecrop herb preparation |
| 11/11/2009 | CN101574383A Prevention and treatment of diseases induced by microcirculation disturbance with panax notoginoside |
| 11/11/2009 | CN101574333A Allitride composition and method for preparing drop therewith for treating nasal cavity infected by microbes and application thereof |
| 11/11/2009 | CN101574149A Sugared ginseng powder medicinal granules and preparation method thereof |
| 11/11/2009 | CN101574148A Ginseng powder medicinal granules |
| 11/11/2009 | CN100558731C Polyether brevetoxin derivatives as a treatment for cystic fibrosis, mucociliary dysfunction, and pulmonary diseases |
| 11/11/2009 | CN100558728C Calcitonin gene related peptide receptor antagonists |
| 11/11/2009 | CN100558724C Sulphonic acid amide for regulating bast peptide activity and derivative thereof |
| 11/11/2009 | CN100558715C Protein kinase inhibitors |
| 11/11/2009 | CN100558712C Therapeutic molecules and methods-1 |
| 11/11/2009 | CN100558410C Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 11/11/2009 | CN100558392C Externally applied medicine for treating infantile pneumonitis, bronchitis and asthma |
| 11/11/2009 | CN100558386C Ginseng glucose injection and its quality control |
| 11/11/2009 | CN100558379C 'Shuang Huang Lian' dispersible tablet and preparation method thereof |
| 11/11/2009 | CN100558372C Medicine composition of compound honeysuckle organic acid and the preparing method of the agent thereof |
| 11/11/2009 | CN100558362C Use of a trioxopyrimidine for the treatment and prevention of bronchial inflammatory diseases |
| 11/11/2009 | CN100558358C Method of treating and diagnosing sleep disordered breathing using zonisamide and means for carrying out the method |
| 11/11/2009 | CN100558353C Application of chlorogenic acid in preparing medicine for treating small cell lung cancer |
| 11/10/2009 | US7615566 Substituted pyrrolidine and related compounds |
| 11/10/2009 | US7615564 Such as N5-[1-(2-chlorobenzyl)tetrahydro-1H-3-pyrrolyl]-5-isoquinolylamine; Rho kinase inhibitors; hypertension, asthma, angina pectoris, cerebrovascular contraction, peripheral circulatory disorder, threatened premature birth, glaucoma, vision disorders, autoimmune diseases, chronic renal failure |
| 11/10/2009 | US7615562 Such as 2-methyl-4-{5-[2-(2,2,6,6-tetramethyl-piperidin-4-ylamino)-pyrimidin-4-yl]-thiophen-2-yl}-butan-2-ol; tumor necrosis factor inhibitors; immunosuppressants; antiinflammatory agents |
| 11/10/2009 | US7615553 E.g., N,N-dimethyl,((5-(hydroxyaminocarbonyl)pyrimidin-2-yl)(piperazin-1,4-ylene)sulfonamide; bioavailability; oral administration; metabolic stability; side effect reduction; psoriasis; anticarcinogenic -proliferative, -arthritic, -inflammatory agent; gene therapy; genetic transcription potentiation |
| 11/10/2009 | US7615550 Such as 1-(4-{[1-(1-methylethyl)-4-piperidinyl]oxy}phenyl)-4-{[4-(methylsulfonyl)phenyl]carbonyl}piperazine; neurodegenerative disorders including Alzheimer's disease; allergic rhinitis |
| 11/10/2009 | CA2481482C Tropane derivatives as ccr5 modulators |
| 11/10/2009 | CA2476257C O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants |
| 11/10/2009 | CA2416785C Novel arylethene-sulfonamides |
| 11/10/2009 | CA2411572C 4,5-dihydro-thiazo-2-ylamine derivatives and their use as no-synthase inhibitors |
| 11/10/2009 | CA2335914C Use of iso-osmotic saline solutions, method for preparing same and medicine based on said solutions |
| 11/10/2009 | CA2197659C Antibacterial composition containing multimeric alpha-lactalbumin |
| 11/05/2009 | WO2009134917A2 Methods for treating inflammation |
| 11/05/2009 | WO2009134856A2 Pharmaceutical gallium compositions and methods |
| 11/05/2009 | WO2009134805A2 Antibodies to granulocyte-macrophage colony-stimulating factor |
| 11/05/2009 | WO2009134524A2 Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations |
| 11/05/2009 | WO2009134203A1 New peptidomimetic compounds |
| 11/05/2009 | WO2009133951A1 Anti-perspiration antigen monoclonal antibody |
| 11/05/2009 | WO2009133831A1 Phenylpropionic acid derivative and use thereof |
| 11/05/2009 | WO2009133294A2 Molecules inhibiting a metabolic pathway involving the syk protein tyrosine kinase and method for identifying said molecules |
| 11/05/2009 | WO2009133136A1 Compounds |
| 11/05/2009 | WO2009112954A3 Processes for the preparation of bosentan and related compounds |
| 11/05/2009 | WO2009046879A3 Use of the combination of npy and nociceptin as a therapeutic agent |
| 11/05/2009 | WO2009046876A3 Use of a peptide as a therapeutic agent |
| 11/05/2009 | WO2009043526A3 Use of gip ( 6-30) alone or in combination with hgh as a therapeutic agent |
| 11/05/2009 | WO2009040051A9 Use of the peptide rfmwmk alone or in combination with the peptide ymdgtmsqv as a therapeutic agent |
| 11/05/2009 | WO2009040005A9 Use of the peptide rfmwmr as a therapeutic agent |
| 11/05/2009 | WO2009033819A3 Use of glicentin-related polypeptide and apelin- 13 in combination as therapeutic agents, eg for treating aids |
| 11/05/2009 | WO2009033797A3 Use of apelin-17 and peptide yy as therapeutic agents, eg for treating hbv infection |
| 11/05/2009 | WO2009033785A3 Use of alpha-casein (90-96) as a therapeutic agent in eg the treatment of hiv infection |
| 11/05/2009 | WO2009033784A3 Use of apelin-13 (qrprlshkgpmpf) and optionally aplha-casein (90-96) as a therapeutic agents in eg the treatment of hiv infection |
| 11/05/2009 | WO2009033738A3 Use of glucagon (1-29) alone or in combination with neuropeptide w30 as a therapeutic agent |
| 11/05/2009 | WO2009033712A3 Use of melanotan ii as a therapeutic agent |
| 11/05/2009 | US20090275662 Injectable veterinary composition |
| 11/05/2009 | US20090275659 Phenyl acetic acid derivatives as inflammation modulators |
| 11/05/2009 | US20090275604 M3 Muscarinic Acetylcholine Receptor Antagonists |
| 11/05/2009 | US20090275576 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-carboxamide derivatives, their preparation and therapeutic use |
| 11/05/2009 | US20090275557 Novel Composition for Treatment of Diseases Related to Activated Lymphocytes |
| 11/05/2009 | US20090275541 Method for treating neurocognitive dysfunction |
| 11/05/2009 | US20090275539 Nuclear Transcription Factors Regulators |
| 11/05/2009 | US20090275537 Certain chemical entities, compositions, and methods |
| 11/05/2009 | US20090275520 Mucin hypersecretion inhibitors and methods of use |
| 11/05/2009 | US20090275516 Compounds and method for modulating inflammatory reactions |
| 11/05/2009 | US20090274771 Compositions and methods for treating asthma and other lung disorders |
| 11/05/2009 | US20090274706 Antibodies to granulocyte-macrophage colony-stimulating factor |
| 11/05/2009 | US20090274691 Use of CD25 binding molecules in steroid-resistant patients |
| 11/05/2009 | US20090274687 Attenuation of hypoxia induced cardiovascular disorders |
| 11/05/2009 | US20090274680 Human Phospholipases |
| 11/05/2009 | US20090274676 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a pde-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease |
| 11/05/2009 | US20090274665 Stem Cells For Treating Lung Diseases |